PROCLAIM IL-2 Registry
(PROLEUKIN® Observational Study to Evaluate the Treatment Patterns and Clinical Response in Malignancy)
What is the PROCLAIM Registry?

PROCLAIM is a US-based multi-center observational study designed to capture real-world clinical data on interleukin-2 when it is used to treat patients with metastatic melanoma, renal cell carcinoma, or other malignancies, whether as a sole therapy or when it is used in conjunction with other agents.

For health care professionals interested in more information about PROCLAIM, please visit the investigator portal for the query process, yearly reports, and other educational materials.

  • Collect and analyze information on current IL-2 use
  • Survey the difference in administration approaches for their respective effect on outcomes
  • Evaluate efficacy of IL-2 on response and survival in the treatment of malignant diseases
  • Identify patient and practice specific prognostic factors
  • Study the impact of new therapies on IL-2 safety and efficacy
PROCLAIM participating sites
# State Registry Site Principle Investigator
1AZThe University of Arizona Cancer CenterSrinath Sundararajan, MD
2CAUniversity of California San DiegoGregory Daniels, MD PhD
3CAUSC Norris Comprehensive Cancer CenterJames Hu, MD
4CAKaiser Riverside OncologyHelen Moon, MD
5COUniversity of Colorado Cancer CenterRene Gonzalez, MD
6FLH. Lee Moffitt Cancer Center and Research InstituteMayer Fishman, MD PhD
7FLMount Sinai Medical Center Comprehensive Cancer CenterJose Lutzky, MD
8FLUniversity of MiamiLynn Feun, MD
9GAWinship Cancer Institute Emory UniversityDavid Lawson, MD
10HIUniversity of HawaiiClayton Chong, MD
11IAUniversity of Iowa Hospitals and ClinicsMohammed Milhem, MD
12ILLoyola University Medical CenterJoseph Clark, MD
13ILOncology Specialists, SCSigrun Hallmeyer, MD
14INIndiana University Simon Cancer CenterTheodore Logan, MD
15KSUniversity of Kansas Medical CenterGary Doolittle, MD
16LAHematology/Oncology Clinic, LLPGerald Miletello, MD
17MABeth Israel Deaconess Medical CenterDavid McDermott, MD
18MDJohn Hopkins University School of MedicineWilliam Sharfman, MD
19MIBarbara Ann Karmanos Cancer InstituteUlka Vaishampayan, MD
20MIUniversity of MichiganAjjai Alva, MD
21MIUniversity of MichiganChristopher Lao, MD
22MNUniversity of Minnesota Masonic Cancer CenterShernan Holtan, MD
23MOSaint Louis UniversityJohn Richart, MD
24NCCarolinas HealthCare SystemAsim Amin, MD PhD
25NCDuke University Medical CenterMichael Morse, MD
26NCWake Forest University Baptist Medical CenterPerry Shen, MD
27NENebraska Cancer SpecialistRalph Hauke, MD
28NHDartmouth Hitchcock Medical CenterLionel Lewis, MD
29NJRutgers Cancer Center Institute of New JerseyHoward Kaufman, MD
30NYSaint Luke’s-Roosevelt Hospital CenterSeth Cohen, MD
31NYColumbia University Medical CenterBret Taback, MD
32NYState University of New York Upstate University HospitalRahul Seth, D.O., MD
33OHUniversity Hospitals Siedman Cancer CenterHenry Koon, MD
34OHThe Christ Hospital Cancer CenterPhilip Leming, MD
35OHUniversity of CincinnatiNagla Karim, MD
36ORProvidence Portland Medical CenterBrendan Curti, MD
37PAUniversity of Pittsburgh Cancer Institute, Melanoma CenterJohn Kirkwood, MD
38PASaint Luke’s Hospital and Health NetworkSanjiv Agarwala, MD
39TXThe University of Texas M.D. Anderson Cancer CenterSapna Patel, MD
40UTHuntsman Cancer InstituteNeeraj Agarwal, MD
41WAUniversity of WashingtonScott Tykodi, MD, Ph.D.
42WIWheaton Franciscan Cancer CareJonathan Treisman, MD
Contact Us
Privacy Policy
Legal Notices
Last Updated: 8/3/2016